Varenzin™-CA1 for Cats & Dogs - Advanced Oral Therapy for Chronic Kidney Disease-Associated Anaemia

Treat CKD-Associated Anaemia Without Injections

Anaemia is one of the most debilitating complications of chronic kidney disease — leaving your cat or dog lethargic, weak, and struggling to enjoy daily life. Varenzin™-CA1 (Molidustat Oral Suspension) is a next-generation oral therapy that stimulates your pet's own body to produce more red blood cells, restoring energy and vitality without the stress of injectable treatments.

How Varenzin™-CA1 Works

Varenzin™-CA1 targets the hypoxia-inducible factor (HIF) pathway — the body's natural oxygen-sensing system. By activating this pathway, it stimulates endogenous erythropoietin (EPO) production, which in turn drives healthy red blood cell formation. This approach works with your pet's own biology rather than introducing external hormones.

Why Choose Varenzin™-CA1?

• No injections required — a convenient once-daily oral suspension that's easy to administer at home
• Stimulates natural EPO production — activates the HIF pathway to support the body's own red blood cell generation
• Improves quality of life — helps restore energy, appetite, and vitality in anaemic pets
• Suitable for cats and dogs — formulated for companion animals with CKD-associated anaemia
• Next-generation HIF-PHI therapy — a modern alternative to traditional injectable erythropoiesis-stimulating agents (ESAs)

Product Details

• Active Ingredient: Molidustat (HIF prolyl hydroxylase inhibitor)
• Formulation: Oral suspension
• Concentration: 25 mg/ml
• Pack Size: 27 ml
• Indication: Anaemia secondary to chronic kidney disease (CKD) in cats and dogs

Recommended Use

Varenzin™-CA1 is a veterinary-prescribed therapy. Dosage is determined by your veterinarian based on your pet's weight, haematocrit levels, and CKD stage. Regular blood monitoring is recommended to ensure optimal response and safety throughout treatment.